skip to Main Content
Get your free newsletter: Actionable insight each morning for self-directed investors. 

GrowGeneration (NASDAQ:GRWG), the Denver-based hydroponics chain, has recently reported a massive increase in revenue in its preliminary full-year 2020 results.

Up 140% from the same period last year, revenue now stands at $192 million. In Q4 2020 alone, revenue rose 142% to $61.5 million, versus $25.4 million for Q4 2019.

Founded in 2014, GrowGeneration owns specialised hydroponic and organic garden centres. Hydroponics is an agricultural technique using mineral nutrients and water solution instead of soil to grow plants. These systems are used to maximise efficiency in crop cultivation, controlling the growing environment, reducing the number of pests and weeds while encouraging rapid plant growth.

Growing acceptance of marijuana in US market

The firm currently has 39 stores – 14 of which were acquired in 2020 – across the US in states such as Colorado, California, Nevada and Washington. It carries and sells thousands of products, including organic nutrients and soils, advanced lighting technology and state-of-the-art hydroponic equipment to be used indoors and outdoors by commercial and home growers.

General gardening products are available in the stores, but with the North American legal marijuana market currently valued at $30.1 billion and set to grow at a compound annual growth rate of 15.5% to around $73.6 billion by 2027, according to Grand View Research, increasingly the main focus for GrowGen is going to be selling equipment to grow marijuana.

This forecast is based on the growing acceptance and adoption of legal marijuana for the treatment of chronic diseases like cancer as well as neurological problems such as epilepsy or depression. And if the Marijuana Opportunity Reinvestment and Expungement (More) Act passes in the US Senate the market could open up even further.

A date for your diary

On the 21st of October, Stuart Fieldhouse will be joining Sarah Lowther and Mark Watson-Mitchell to discuss which small cap investments they like the look of and, perhaps, which ones they do not. It promises to be a lively and insightful discussion. If you are interested in investing in small cap stocks then this could be a profitable use of your time. We hope you can make it! Sign up now

Growth through acquisition and sales

More specifically, GrowGen’s CEO attributes the triple-digit revenue growth to “strategic acquisitions of best-in-class hydroponic stores, exceptional same-store sales growth, and the expansion of our omnichannel and private label offerings.” Same-store sales were up 63% for the full-year 2020 versus full-year 2019 and in Q4, were up 58% for Q4 2020 versus Q4 2019.

CEO Darren Lampert expects further significant revenue growth this year as the firm plans to accelerate their growth strategy. It has increased the projected number of operating garden centres in 2021 to 55.

GrowGeneration also anticipates increased revenue guidance for this year to $335-$350 million, up $50 million from the Q3 2020 financial results which had stated revenue guidance as $280-300 million. The firm has also raised its 2021 adjusted EBITDA guidance to $38-$40 million.

As with many other cannabis-related stocks, the share price has risen dramatically in the last year. In January 2020 the share price was $4 and at time of writing it is around $50 per share. Analysts quoted on Nasdaq believe there is still some way to go and are currently rating GrowGen as a buy.

Related

Become a better investor with SharePad Designed to give you the confidence to pick your own investments, Sharepad gives you access to a wealth of information on UK, US & European stocks. Find out more

Please note this article does not constitute investment advice. Investors are encouraged to do their own research beforehand or consult a professional advisor.

Philippa Aylmer

Philippa Aylmer

Philippa Aylmer is a freelance writer within the investment management sector.

She began her career in the late 90s writing about emerging markets for the Euromoney titles while based in Pakistan. Since then, she has covered hedge funds, ETFs, wealth management and fintech.

As well as news, on the client side, Philippa advises on media relations and editorial strategy, writing about the topical and technical issues of investment management

Stocks in Focus

Here are some of the smaller companies we are following most closely. They all represent significant growth stories in our view. Our in-depth reports go into more detail on why we like them.

Comments

A date for your diary

On the 21st of October, Stuart Fieldhouse will be joining Sarah Lowther and Mark Watson-Mitchell to discuss which small cap investments they like the look of and, perhaps, which ones they do not. It promises to be a lively and insightful discussion. If you are interested in investing in small cap stocks then this could be a profitable use of your time. We hope you can make it! Sign up now

Get your free daily newsletter: 

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

Pepperstone
FP Markets
IG
Spreadex
Trade Nation
WisdomTree
ActivTrades
Back To Top